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Purpuric skin lesions often result from thrombocytopenia or
generalized vasculitis involving the small vessels of the skin.
Both conditions are sometimes associated with an abnormal
immune response to an infection. Acquired cytomegalovirus
(CMV) infection has been associated infrequently with
immune thrombocytopenic purpura (ITP) and very rarely with
vasculitic purpura. We herein report the case of an infant with
acquired CMV infection who developed purpura, possibly
caused by both thrombocytopenia and vasculitic processes.
A previously healthy 2-month-old boy was referred to
Sasebo City General Hospital due to a 2 days history of fever
and runny nose. His perinatal history was uneventful without
any signs suggestive of congenital CMV infection. His general
condition was good, and physical examination was normal. On
laboratory analysis, white blood cell count was 11 840/lL with
37% neutrophils, platelet count was 140 000/lL, C-reactive
protein (CRP), 1.72 mg/dL; aspartate aminotransferase (AST),
72 IU/mL; and alanine aminotransferase (ALT), 55 IU/mL.
After he was started on ampicillin (100 mg/kg/day) and cefo-
taxime (100 mg/kg/day), he became afebrile and was dis-
charged on day 4. At day 8 when he had a blood sample taken at
an outpatient clinic, multiple prominent purpura rashes emerged
in his arm peripherally from the tourniquet (Fig. S1). On blood
test, platelet count was 45 000/lL; immature platelet fraction,
13.3%; fibrinogen/fibrin degradation product (FDP), 6.0 lg/mL
(normal range, <5.0); D-dimer, 3.1 lg/mL (normal, <1.0); CRP,
0.52 mg/dL; AST, 204 IU/mL; and ALT, 124 IU/mL.
Prothrombin time (PT), activated partial thromboplastin time
(APTT), and fibrinogen were within the normal range. He was
hospitalized again with a diagnosis of ITP. Given that the plate-
let count had decreased to <30 000/lL, he was given i.v.
immunoglobulin (IVIG; 1 g/kg/day for 2 days), leading to a
prompt increase in platelet count. He was discharged on day 14.
Although the platelet count increased to 180 000/lL, he devel-
oped multiple purpura rashes peripherally from the tourniquet
and mild bloody stool on day 21 (Fig. 1). Subsequently, his
serum was found to be negative for parvovirus B19-IgM but
positive for CMV-IgM antibody and CMV-DNA (1,400 copies/
mL) on day 10. The purpuric lesions gradually improved with-
out relapse during a 6 months follow-up period after discharge.
Cytomegalovirus infection has been infrequently associated
with ITP in Japan. Kawasaki et al. reviewed pediatric cases of
CMV-associated ITP, in which most of the patients had platelet
count <30 000/lL and high AST and ALT. None of those patients
developed severe bleeding. Prompt improvement was observed
after treatment with steroid and/or IVIG, except in one case, sug-
gesting an immunopathological mechanism in most cases.1
Cytomegalovirus-associated vasculitic purpura in immuno-
competent hosts is very rare. The vasculitis may result from
direct vascular injury through viral proliferation at the vascular
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wall or from indirect vascular injury through immunopathologi-
cal mechanism. On a literature search, only three pediatric cases
of CMV-associated vasculitis were identified.2–4 One of them
might have been a case of congenital CMV infection, and
another was thought to be CMV reactivation induced by steroid
therapy. The third involved a patient with CMV mononucleosis
syndrome who was not immunocompromised, and a punch
biopsy specimen taken from the papular lesion showed an
inflammatory process of the upper and middle dermis with lym-
phocytic vasculitis. None of these patients had ITP.
In the present case, thrombocytopenia existed and appeared
to respond to IVIG therapy promptly, but the patient devel-
oped purpura and bloody stool even after the platelet count
had returned to normal. The transient clinical course and coag-
ulation studies (PT, APTT and fibrinogen) did not indicate a
congenital etiology or coagulation disorder, and the elevated
FDP and D-dimer suggested vascular injury. Therefore, it is
possible that mucocutaneous vasculitis contributed to the pur-
pura and bloody stool in this patient.
The major limitation in this report is that we were unable
to perform a skin biopsy because the patient’s clinical condi-
tion was stable. Despite the lack of histological confirmation,
we believe that infection with a common virus, such as CMV,
could lead to mucocutaneous bleeding through two different
immunopathological processes: thrombocytopenia and possible
vasculitis.
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Fig. S1 Multiple purpura rashes induced peripherally by the
tourniquet at day 8.
Fig. 1 Clinical course. ABPC, ampicillin; ALT, alanine aminotransferase; AMPC, amoxicillin; CMV, cytomegalovirus; CTX, cefotaxime;
div, intravenous drip; EBV, Epstein–Barr virus; IVIG, i.v. immunoglobulin; PLT, platelets; p.o., per os; VCA, viral capsid antigen.
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